In English
NIDA

Infectious Diseases

Study Endorses Onsite HIV Testing Without Risk Reduction Counseling

Patients were more likely to take a rapid HIV test when substance abuse treatment programs offered the test onsite rather than referred for offsite testing. Patients were equally likely to accept and learn their HIV status whether the offer of onsite testing was accompanied by 30 minutes of risk reduction counseling or by 5 minutes of brief information on the testing procedure. Onsite testing accompanied by brief information was cost effective, taking into account the projected lifetime costs of treatment and the gains in health and longevity for detected cases.

Seek-Test-Treat-Retain To Stop the Spread of HIV

NIDA Director Nora Volkow

Despite the advances in treatment and prevention, roughly 50,000 new HIV infections still occur annually in the Nation. Research, in large part supported by NIDA, has produced a strategy to address this circumstance and break the epidemiological impasse: seek out HIV-infected individuals, particularly those in “hard-to-reach” groups that have minimal contact with the health care system; offer them HIV testing and treatment; and provide support to help them stay in treatment.

Antiretroviral Treatment Reduces Spread of HIV Among Injection Drug Users

Expanded use of antiretroviral therapy in British Columbia reduced the spread of HIV among injection drug users and others in the province.

Desafío nacional sobre el Coeficiente Intelectual (IQ) de las drogas

Un examen de 12 preguntas que anima a las personas a poner a prueba su conocimiento sobre el abuso de drogas y la adicción. Las respuestas muestran el enlace entre la ciencia y el abuso de drogas.

Actualizada en: diciembre del 2012
Autor: Array

Drugs Contribute to High Rates of Sexually Transmitted Diseases Among Juvenile Offenders

Describe a study of newly arrested youths where researchers found correlations between the youths' prevalence of these sexually transmitted diseases and their cocaine and marijuana use.

Study Gives Green Light to Antiretroviral Medications for HIV-Infected Injection Drug Users

Reports finding from a study showing that access to antiretroviral therapies, HAART in particular, can improve the health of HIV-infected patients who have a history of injection drug use.

Nota de la Directora

Es difícil creer que la epidemia del virus de la inmunodeficiencia humana (VIH)/síndrome de inmunodeficiencia adquirida (SIDA) ya tiene un cuarto de siglo de estar entre nosotros. Hoy en día, tenemos una generación entera de adultos jóvenes que no ha conocido un mundo libre del VIH/SIDA.

El VIH/SIDA

Explora el vínculo entre el abuso de drogas y el VIH/SIDA y analiza las opciones de tratamiento, las poblaciones de mayor riesgo y las tendencias emergentes en las infecciones por VIH/SIDA y qué hacer para contrarrestar estas tendencias.

Impresa en: julio del 2006
Autor: Array

Letter from the Director

Human immunodeficiency virus (HIV) — the virus that causes acquired immune deficiency syndrome (AIDS) — has been with us for three decades now. Today, an entire generation of young adults has never known a world without HIV/AIDS.

Pages

Subscribe to RSS - Infectious Diseases

Attention

Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas